Skip to main content
Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · IEX Real-Time Price · USD
5.05
-0.46 (-8.44%)
At close: Jul 19, 2024, 4:00 PM
4.990
-0.050 (-1.09%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Marker Therapeutics Revenue

Marker Therapeutics had revenue of $3.32M in the twelve months ending March 31, 2024. Revenue in the quarter ending March 31, 2024 was $1.24M with 0.79% year-over-year growth. In the year 2023, Marker Therapeutics had annual revenue of $3.31M.

Revenue (ttm)
$3.32M
Revenue Growth
-12.23%
P/S Ratio
13.55
Revenue / Employee
$415,107
Employees
8
Market Cap
45.00M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20233.31M-202.41K-5.76%
Dec 31, 20223.51M2.27M182.96%
Dec 31, 20211.24M774.93K166.01%
Dec 31, 2020466.79K253.59K118.95%
Dec 31, 2019213.19K7.20K3.50%
Dec 31, 2018205.99K22.93K12.53%
Dec 31, 2017183.06K--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Dec 31, 20120--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

MRKR News

More News